Testing ST266 in Babies with NEC
Part of Digestive system clinical trials.
This study tests an investigational drug called ST266 in babies with necrotizing enterocolitis (NEC), a serious gut infection. The goal is to see if it is safe and can help heal the bowel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 22 and 40 weeks of pregnancy and now weighs between 500 grams (about 1.1 pounds) and 3000 grams (about 6.6 pounds).
- Your baby has been diagnosed with Bell's Stage IIA or higher NEC, meaning there is air in the bowel wall seen on an X-ray or ultrasound.
- Your baby does not have a hole (perforation) in the bowel and does not need immediate surgery.
- Your baby is expected to live at least 2 weeks and does not have a life-limiting condition.
- Your baby does not have another serious medical condition (like major birth defects, bleeding disorders, or a weak immune system).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study interviews surgeons who treat infants with a serious bowel condition called necrotising enterocolitis (NEC). Researchers want to understand how surgeons make decisions and how babies do afterward.
This study looks at whether newborns with a serious gut condition called necrotizing enterocolitis (NEC) have different allergy triggers compared to healthy newborns. It may help doctors understand if allergies play a role in NEC and could guide future treatments.
This study looks at how newborns with urgent digestive system problems are treated and how they recover. It may help doctors improve care for babies with similar emergencies.
This study looks at the long-term health and development of children who were born very early and had a serious gut problem (NEC or a bowel perforation). By comparing these children with others born just as early but without these issues, the study aims to understand how these conditions affect growth and health over time.
This study looks at how the intestines grow and develop in both premature and full-term babies. It involves collecting small tissue samples during a baby's already-planned surgery or scope procedure to better understand normal development and digestive diseases.
This study looks at whether giving probiotics (good bacteria) to very premature babies (born before 32 weeks) can lower the risk of a serious gut problem called necrotizing enterocolitis (NEC). The researchers will review medical records of babies born between 2016 and 2022 in England and Wales.
Hear when a new Necrotizing Enterocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.